Most of the men who ask us about Ozempic have already read the side effect list online. The list is long. The list is also flattened: every side effect appears equally weighted, with no sense of which ones happen to most patients and which ones make the news because they almost never happen.
This piece reorders the list by clinical reality. Common, serious, and rare are three different categories, and the protocol changes depending on which one shows up.
What is Ozempic?
Ozempic is the brand name for semaglutide, a once-weekly injectable GLP-1 receptor agonist. It is FDA-approved for type 2 diabetes. Wegovy is the same molecule at a higher dose, approved for weight management. The side effect profile is essentially the same across both brands, since the molecule and route are the same.
Common Ozempic side effects
These are the side effects most men will experience to some degree, especially in the first 4 to 8 weeks of use or after a dose increase.
Nausea
The most reported side effect. Roughly 40% to 45% of patients in the trials reported nausea at some point. Usually mild to moderate. Usually worst in the first 1 to 2 weeks after starting or after a dose escalation. Usually resolves with continued use.
Management: smaller meals, eat slowly, avoid greasy or high-volume meals, consider taking the dose in the evening rather than the morning, ginger or peppermint as adjuncts. Anti-nausea medication is rarely needed and should be a clinician conversation, not a self-prescribe.
Constipation
About 20% to 30% of patients. Slowed gastric emptying applies to the whole GI tract, not just the stomach. Fiber intake usually drops on a GLP-1 because total food intake drops, which compounds the issue.
Management: hydration, soluble fiber (psyllium, oats, legumes), magnesium glycinate or citrate in the evening, regular physical activity. Stool softeners or osmotic laxatives if persistent.
Diarrhea
About 10% to 15% of patients. Less common than constipation but appears especially during titration or after dose increases. Usually self-limiting.
Management: hydration, electrolytes, smaller meals. If persistent past a week, talk to your clinician.
Reduced appetite
Not technically a side effect (it is the mechanism), but worth naming. Most patients describe a meaningful reduction in food noise and a sense of fullness with smaller meals. For some, this becomes an issue when food enjoyment drops more than expected, or when total protein intake falls below the floor needed to protect lean mass. We cover the lean-mass piece in Muscle loss on GLP-1s.
Fatigue
About 5% to 10% of patients, usually early. Often tied to undereating during the initial appetite drop. Resolves when calorie and fluid intake stabilizes.
Serious Ozempic side effects
These are uncommon but consequential. Worth knowing the signs and worth a clinical evaluation if they appear.
Pancreatitis
Reported in the post-marketing data. Causal relationship is debated; absolute risk is low. Symptoms: persistent, severe upper abdominal pain (often radiating to the back), often with nausea and vomiting that does not resolve.
If this pattern shows up, stop the medication and seek evaluation that day. Pancreatitis is a clinical and lab diagnosis, not a guess.
Gallbladder problems (cholelithiasis, cholecystitis)
Rapid weight loss from any cause increases gallstone risk. GLP-1s contribute. Risk scales with rate of loss. Symptoms: right upper quadrant pain, especially after fatty meals, sometimes with fever, nausea, jaundice.
Risk is meaningfully higher in patients losing weight rapidly. A slower loss rate (which is also better for muscle preservation) reduces this risk.
Severe gastroparesis
A subset of patients develop more persistent gastric emptying delays that do not resolve with continued use. Reversible after stopping the medication in most cases. Symptoms: persistent nausea after small meals, vomiting of food eaten hours earlier, early fullness.
We screen for prior gastroparesis or significant reflux disease before starting. If symptoms develop, the drug usually stops.
Hypoglycemia
Rare in non-diabetic patients on Ozempic alone. More common in patients on concurrent insulin or sulfonylureas, where the dose of those medications usually needs to drop.
Rare but serious Ozempic side effects
Medullary thyroid carcinoma (MTC) risk
The black-box warning. Based on rodent studies. Human evidence is much weaker. Still, we do not prescribe GLP-1s to patients with a personal or family history of MTC or multiple endocrine neoplasia syndrome type 2 (MEN-2). Routine thyroid surveillance is not part of standard GLP-1 follow-up in patients without those risk factors.
Allergic reactions
Rare, occasionally serious. Hives, swelling, breathing difficulty after injection. Discontinue and seek care.
Acute kidney injury
Usually secondary to severe vomiting and dehydration, not direct kidney toxicity. Manageable with hydration and dose adjustment.
Diabetic retinopathy progression
Documented in patients with pre-existing retinopathy and rapid A1c reductions. Relevant for diabetic patients more than non-diabetic weight-loss patients.
"Ozempic face"
The hollowed-out facial appearance some patients develop is real, but it is not a unique Ozempic phenomenon. It is the appearance of any rapid weight loss from any cause. Subcutaneous facial fat is among the first compartments to mobilize during a sustained deficit.
The lever is rate of loss, not the drug. Slower weight loss preserves more facial fat. A man losing 0.5% to 1% of body weight per week will rarely develop the "face" effect. A man losing 2% per week often will.
How to manage common side effects
A practical hierarchy that resolves most early GI effects:
- Slow the titration. If you escalated to a new dose and the GI side effects spiked, drop back to the prior dose for 2 to 4 weeks before reattempting.
- Reduce meal volume. Smaller, more frequent meals beat large meals at this stage.
- Hydrate aggressively. Most early GI effects worsen with mild dehydration.
- Time the dose. Some men do better with evening injections. Others with morning. Experiment.
- Protein floor. Keep protein at 1.6 g/kg even when not hungry. This protects lean mass and stabilizes meal patterns.
- Move daily. Even a 20-minute walk supports GI motility and offsets some constipation.
If symptoms persist past 4 to 6 weeks at a stable dose, the medication may not be a fit, and a clinical conversation about switching molecules or stopping is reasonable.
Where this lands
Ozempic is a safe medication when used with intent. The common side effects are predictable, manageable, and usually resolve. The serious side effects are real but rare. The rare side effects are the ones that make headlines despite being rare.
The protocol around the medication matters more than the side effect list. Slow titration, protein floor, modest loss rate, and a clinician reading the labs every quarter prevent most of the issues that get attention online. We cover that broader protocol in the GLP-1 explainer.
If you are weighing Ozempic against tirzepatide, the side effect profiles are more similar than different. The decision usually comes down to other factors.
